Phase II study of weekly paclitaxel and carboplatin followed by oral navelbine in patients with triple negative metastatic/recurrent breast cancer previously treated with adjuvant anthracycline and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback